Enzene Biosciences Ltd

Peer into the crystal ball with us this #Halloween and discover what’s next for biologics Manufacturing! Fully Connected Continuous Manufacturing™ (FCCM)™ is transforming biologics with benefits like seamless scalability, increased productivity, and sustainability—all revealed in clear view. At Enzene, we’re pioneering tomorrow’s biologics manufacturing today. Wishing you a Halloween full of treats! Happy Halloween 🎃 #HappyHalloween #TricksOrTreat #biologics #biopharma

Are you looking to reduce environmental impact without sacrificing productivity? Discover how our Fully-Connected Continuous Manufacturing™ technology that enables up to 50% reduction in the carbon footprint of biologics manufacturing. Through EnzeneX™, we’re helping you make a difference—smaller facility sizes, optimized resource use, and higher productivity for a sustainable future in biologics. Click the link in the comments to know more. #Biologics #SustainableManufacturing #CDMO

Imagine it as "Netflix without ads", enabling a fully automated, dynamic system without pauses or hold steps. Catch our CEO Himanshu Gadgil in an interview with Pharmaceutical Technology, delve into the transformative power of Fully-connected continuous manufacturing™ (FCCM™) for #biologics. Click the video link below to watch the full interview and learn how FCCM™ is setting a new benchmark in the industry. https://lnkd.in/e4u-tSbM #CPHI2024 #innovation #FCCM #mAbs #continuousmanufacturing

We recognize the urgency of an #accessible and #sustainable future in #biologics manufacturing and are ready to make the impact that matters! Explore this insightful article from Enzene, where we highlight the key drivers of change in the biologics industry and showcase our innovative approach that is poised to make our vision a reality! #biologics #innovation #fullyconnectedcontinuousmanufacturing #EnzeneX

Join Our Team of Experts at BIO-EUROPE 2024!   1. Discover the cost-saving, #productivity-boosting, and #sustainability advantages of our fully-connected continuous manufacturing™ platform for #biologics with Wouter Huizinga. 2. Engage with Nikita B. to learn more about our extensive #biosimilar portfolio and key territories of interest.   We're looking forward to exploring opportunities for #collaboration with you in this ever-evolving #biotech landscape. See you in Sweden!   To book a meeting, message our team or hit the link below: https://lnkd.in/ddAY-gq3

“My first piece of advice is, solve the problem and scale the solution. Putting this into practice means creating a workflow that is robust both in terms of effectiveness and efficiency”, says Sundar Ramanan, PhD, MBA, Chief Quality Officer at Enzene. Don't miss this insightful interview with European Pharmaceutical Review, where Sundar discusses how Enzene is harnessing the shift to FCCM™ for #biologic therapies. To learn more about the cutting-edge innovations driving the future of biologics production and how they enable greater #efficiency, #sustainability and #scalability turn to page 7 of the link below: https://lnkd.in/eX-aqeJf

New #whitepaper alert📜 Read now! Authored by Abhishek Mathur, PhD, MBA (SVP, Head of R&D) our latest whitepaper explores "Unlocking Efficiency and Quality in Fully-Connected Continuous Manufacturing™ through AI and ML!" #Drugdiscovery #ArtificialIntelligence #AI #MachineLearning #ML

Here’s a glimpse of our Head of Cell Line Engineering, Arindam Chakraborty’s session at the Festival of Biologics 2024! Arindam shared key insights into breaking the $40/gram barrier for mAbs using our fully-connected continuous manufacturing™ (FCCM™) technology. Some of the benefits he highlighted include: ✅ Cost Reduction: FCCM™ technology is significantly lowering the cost of mAb production, making treatments more affordable by bringing costs below $40 per gram for mAbs. ✅Increased Productivity: FCCM™ streamlines the entire process, enabling higher yields, which translates to quicker time-to-market for life-saving biologics. ✅Sustainability: FCCM™ reduces the manufacturing plant footprint, minimizing energy consumption and resource use, contributing to greener and more sustainable biologics production. ✅ Accessibility: By lowering costs and increasing production efficiency, FCCM™ is helping make critical treatments more accessible to patients worldwide. #FOB #FestivalOfBiologics #biologics #MonoclonalAntibodies

Watch now! Day 2 of the Festival of Biologics 2024 features Russell Miller, our Vice President of Global Sales and Marketing in an interview with Rizwan Chaudhrey highlighting our Fully-Connected Continuous Manufacturing™ (FCCM™) technology. He shares as the pioneers of FCCM™, how we are driving efficiency and affordability in biologics manufacturing by bringing the cost of mAbs down to $40 per gram. To learn more do drop by our booth #828. See you soon. #FestivalOfBiologics #biologics #MonoclonalAntibodies #mAbs